From bases to breakthroughs: Editing cancer’s weak spots with CRISPR

2026-05-26T13:53:09+01:0026 May 2026|

In the latest installment of our innovator blog series, we caught up with Dr Matthew Coelho, Cancer Research UK Career Development Fellow at the Wellcome Sanger Institute. Matthew works within the Somatic Genomics programme and is co-founder of BASE Rx alongside Group Leader, Dr Mathew Garnett.

Building a community at the frontline of cholera genomics

2025-09-04T14:01:06+01:004 September 2025|

In this eighth part of our innovator blog series, we spoke to Dr Jolynne Mokaya, Public Health Lead at the Wellcome Sanger Institute. With an entrepreneurial and ingenious spirit, Jolynne is helping to build a community of practice of cholera experts that will facilitate and progress research by leveraging regional expertise across several continents.

Accidental Entrepreneur

2024-07-05T10:42:40+01:0023 March 2023|

In this third part of our innovator blog series, we spoke to Matt Hurles, Head of the Human Genetics programme and incoming Director of the Wellcome Sanger Institute. Matt defines himself as an accidental entrepreneur, even though he spearheads a number of innovative initiatives that showcase his motivation to ultimately bring benefits to patients.